Facebook-f Linkedin-in

News & Views

Business Development
Partnering
Drug Development
Innovation
Corporate Strategy
Insights
Capital Markets
Biotech Structuring
Deal Making
Did You Know?
Business Development
Partnering
Drug Development
Innovation
Corporate Strategy
Insights
Capital Markets
Biotech Structuring
Deal Making
Did You Know?
Man with binoculars representing strategic recruiting and hiring solutions

A Forced Transition

Running a healthy efficient business is a full-time task for senior management during normal times. The unprecedented transition into a world of uncertainty, paired with unclear timing and nature of recovery, present not only new challenges to navigate but also an unprecedented volume of forced “restructuring” in our industry...
Read More

Pharma’s Path Through Industry Turbulence

Read More

Neurology M&A – Treehill Quotes in Endpoints News

Read More

Treehill Partners CEO Featured in Newsweek Coverage of TrumpRx Initiative

Read More

Treehill Partners Experts Featured in FirstWord Report on Biomarkers in Rare Disease Therapies

Read More

Keep the Patients in Mind

Read More
Graph illustrating the impact of the 1918 influenza pandemic in Philadelphia

Corona

Whilst Corona virus news are out there loud and clear, a mindset of “I would survive hence will be taking my chance” made us pause and reply, calmly, that yes you likely would but could carry it to those who would not – and that is the problem. We point out the often quoted comparison of 1918 flu epidemic responses between the two cities...
Read More

Navigating Biotech’s Perfect Storm: Pharmaphorum Podcast

Read More

Optimizing Biomanufacturing

Read More

The Biotech Funding Model Needs a Major Overhaul

Read More

When VC Steps Back: Finding Alternative Biotech Funding

Read More

“We’re making the same mistakes over and over”

Read More

Biotech Capital Raising Insights

Treehill Partners operates extensive Healthcare Investment Banking services and world class biotechnology Strategy Consulting as well as Leadership Support advisory services to some of today’s most innovative industry leadership teams. Over the years, as we evaluate investment proposals put forward to corporates, venture capitalists...
Read More

Can Europe take the lead on biotech?

Read More
Healthcare facility in China with medical staff, as covered by Bloomberg in mid-2025

China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline

Chinese biotech's advance has been as ferocious as the nation's breakthrough efforts in AI and EVs, eclipsing the EU and catching up to the US...
Read More
Double exposure image combining a world map, business meeting at a round table, and businessman discussing unfundable gaps

Unfundable Gaps – Treehill CEO quoted in BioSpace

Companies are being asked to take-on increasingly complex challenges in an environment where there are diminished resources...
Read More
Business partners shaking hands during a meeting to finalize an agreement

“I wish you’d called us before you’d run that Phase II” – Ali Pashazadeh, Treehill Partners CEO, in Scrip Interview

Mandy Jackson, US editor of Citeline's Scrip, has published the below interview with Ali Pashazadeh, Treehill Partners CEO...
Read More
Illustration of the BIO Convention logo

From Molecule to Market – BioSpectrum Asia interview with Ali Pashazadeh, Treehill Partners CEO

At this year's BIO Convention in Boston, Ali Pashazadeh, Treehill Partners CEO, spoke with Manasee Kurlekar, BioSpectrum Asia Chief Executive Officer...
Read More

Game Theory & Biotech Alpha Culture

n 1973, John Maynard Smith presented an idea explaining game theory and how alpha culture exists in societies. Maynard’s hypothesis asked you to imagine a world with doves and hawks. If there would be only hawks, their fights would be devastating to their population. If there would be only doves, they would be susceptible to any intruders...
Read More
Illustration of a molecular structure representing biopharma innovation

We need to both Do the Right Thing and Do It the Right Way

Read More
Ali Pashazadeh, founder of Treehill Partners, presenting at a business meeting conference

Biotech, Pharma, Outsourcing & Capital – Podium Discussion at PCMG Annual Assembly

At PCMG Clinical Outsourcing Community today, Ali Pashazadeh, Treehill Partners CEO, was giving a podium presentation on "A view from the top - how will Clinical Development Outsourcing adapt to a rapidly changing landscape"...
Read More
Toys including a teddy bear representing the biopharma and toy tariff discussion

Tariffs On Toys … And API? Biopharma As The Next Battleground – Outsourced Pharma Interview with Treehill Partners CEO, Ali Pashazadeh

Whilst outsourcing of drug development and manufacturing is an attempt to undertake purposeful action in a web of interdependent contingencies, this interview with Ali Pashazadeh, Treehill Partners CEO...
Read More
Medical face mask fading away in artistic powder effect

Evolve Or Fade Away? Biotech’s Outsourcing Moment – Outsourced Pharma interview with Ali Pashazadeh, Treehill Partners CEO

Outsourced Pharma Chief Editor Louis Garguilo has interviewed Ali Pashazadeh, Treehill Partners CEO, to help think through the evolving U.S. policies and tariff turbulance as they relate to the outsourcing of development and manufacturing...
Read More
Pink brick wall with inspirational quotes displayed

Treehill Partners in Pink Sheet’s “Quotable: Top Experts On Policy Hot Topics”

The Pink Sheet and Citeline have just published their summary article 'Quotable: Top Experts on Policy Hot Topics’, picking out 12 recent articles that are ‘must read’....
Read More
Neosurgery medical device displaying brain activity with three doctors observing in the background

The Capital Raising Biotech CEO Whose Calls are not Returned

Many CEOs in biotechnology are focused on reaching out to as many investors as possible in a style that is known to be rather hectic and haphazard. A recent study showed that nearly 80% of institutional investors will not invest in a concept they do not understand scientifically. Saying it another way, if investors do not understand...
Read More
Technical data snippet with numerical values and label KL15

Opportunities & Challenges in the Evolving Regulatory Landscape in Europe – Pink Sheet Interview with Mark Mayhew, Treehill Partners

Pink Sheet, the Citeline regulatory publication, reporter Eliza Slawther has interviewed Mark Mayhew, Treehill Partners...
Read More
Stacks of coins separated by a crack on a surface, symbolizing financial divide or instability.

Filling the NIH Funding Gap to Protect Biopharma Research – BioWorld

Following an interview with BioWorld (top 10 life science publication founded 1991) managing editor Karen Carey, the article recites Ali Pashazadeh, Treehill Partners CEO...
Read More
Illustration of an open door with a person entering, symbolizing navigating financial challenges and exploring future opportunities in the biotech industry

Navigating CGT Biotech’s Financial Headwinds And The Path Forward – Cell & Gene Interview with Ali Pashazadeh, Treehill Partners CEO

Read More
Mergermarket logo representing financial news and M&A intelligence

Global pharma M&A tumult expected as US tariffs threaten supply chain – Mergermarket article quoting Ali Pashazadeh, Treehill Partners CEO

Read More
Mergermarket logo representing financial news and M&A intelligence

EMEA developers of cardiovascular treatments to benefit from weight-loss gold rush – Mergermarket quoting Ali Pashazadeh, Treehill Partners CEO

Read More

Subscribe to our mailings!

Thank You

Please choose your subscriptions:

Unsubscribe any time using the footer of our emails. For information about our privacy practices, please visit our privacy policy.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.